By : iBio, Inc.
Sources :http://www.sacbee.com
Category :Patent News
NEWARK, Del., May 8, 2012 -- /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator™ platform. The new patent, which provides broad protection of the platform, is US Patent 8,173,408, entitled "Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides."
Sources : http://www.sacbee.com/2012/05/08/4474024/broad-patent-protection-granted.html
Sources :http://www.sacbee.com
Category :Patent News
NEWARK, Del., May 8, 2012 -- /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced issuance of a US patent covering compositions of matter and methods of use of modified lichenase B polypeptides comprising the Company's iBioModulator™ platform. The new patent, which provides broad protection of the platform, is US Patent 8,173,408, entitled "Recombinant Carrier Molecule for Expression, Delivery and Purification of Target Polypeptides."
Sources : http://www.sacbee.com/2012/05/08/4474024/broad-patent-protection-granted.html
